Diarrhea-associated biofilm formed by enteroaggregative Escherichia coli and aggregative Citrobacter freundii: a consortium mediated by putative F pili.

Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180 (Electronic) Linking ISSN: 14712180 NLM ISO Abbreviation: BMC Microbiol Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Biofilms/*growth & development ; Citrobacter freundii/*physiology ; Diarrhea/*microbiology ; Enterobacteriaceae Infections/*microbiology ; Enteropathogenic Escherichia coli/*physiology ; Escherichia coli Proteins/*physiology ; Fimbriae Proteins/*physiology; Adhesins, Escherichia coli/genetics ; Anti-Bacterial Agents/pharmacology ; Bacterial Adhesion/drug effects ; Bacterial Adhesion/genetics ; Biofilms/drug effects ; Citrobacter freundii/pathogenicity ; Citrobacter freundii/ultrastructure ; Enteropathogenic Escherichia coli/genetics ; Enteropathogenic Escherichia coli/pathogenicity ; Enteropathogenic Escherichia coli/ultrastructure ; Escherichia coli Proteins/genetics ; Escherichia coli Proteins/metabolism ; Fimbriae Proteins/genetics ; Fimbriae Proteins/metabolism ; Glass ; HeLa Cells ; Humans ; Infant ; Microscopy, Electron, Scanning ; Quorum Sensing ; Zinc/pharmacology

Background: Enteroaggregative Escherichia coli (EAEC) are enteropathogenic strains identified by the aggregative adhesion (AA) pattern that share the capability to form biofilms. Citrobacter freundii is classically considered as an indigenous intestinal species that is sporadically associated with diarrhea.
Results: During an epidemiologic study focusing on infantile diarrhea, aggregative C. freundii (EACF) and EAEC strains were concomitantly recovered from a severe case of mucous diarrhea. Thereby, the occurrence of synergic events involving these strains was investigated. Coinfection of HeLa cells with EACF and EAEC strains showed an 8-fold increase in the overall bacterial adhesion compared with single infections (P < 0.001). The synergic effect was mediated by physical interactions among the bacteria and primed in the absence of chemical signaling and without the participation of host cells. Thus, significant increases (2.7-fold on average) in bacterial adhesion were also observed during the formation of mixed biofilms on abiotic surfaces. Bacterial settling assays showed that EAEC strains harboring F-pili genes (traA) were capable of forming bacterial aggregates only in the presence of EACF. Scanning electronic microscopy analyses revealed that bacterial aggregates as well as enhanced biofilms formed by EACF and traA-positive EAEC were mediated by non-bundle forming, flexible pili. Moreover, mixed biofilms formed by EACF and traA-positive EAEC strains were significantly reduced using nonlethal concentration of zinc, a specific inhibitor of F pili. In addition, EAEC strains isolated from diarrheic children frequently produced single biofilms sensitive to zinc.
Conclusions: Putative F pili expressed by EAEC strains boosted mixed biofilm formation when in the presence of aggregative C. freundii.

J Infect Dis. 1995 Feb;171(2):465-8. (PMID: 7844392)
Annu Rev Microbiol. 2006;60:131-47. (PMID: 16704339)
Can J Microbiol. 1994 Apr;40(4):286-91. (PMID: 7913657)
Plasmid. 2007 Mar;57(2):95-107. (PMID: 17087993)
J Infect Dis. 1989 Jun;159(6):1057-60. (PMID: 2656874)
Infect Immun. 1995 Mar;63(3):1055-61. (PMID: 7868227)
Infect Immun. 2003 Jul;71(7):4151-8. (PMID: 12819107)
Infect Immun. 1997 Oct;65(10):4135-45. (PMID: 9317019)
Infect Immun. 2006 Apr;74(4):2102-14. (PMID: 16552039)
Am J Gastroenterol. 2004 Feb;99(2):383-9. (PMID: 15046233)
J Infect Dis. 2007 Feb 1;195(3):366-74. (PMID: 17205475)
J Infect Dis. 1985 Sep;152(3):560-5. (PMID: 2863319)
Plasmid. 2005 Jul;54(1):1-25. (PMID: 15907535)
Am J Trop Med Hyg. 2004 Nov;71(5):687-90. (PMID: 15569806)
J Bacteriol. 2003 Apr;185(7):2203-9. (PMID: 12644490)
Indian J Pediatr. 1980 Jan-Feb;47(384):81-4. (PMID: 7216341)
J Bacteriol. 1983 Feb;153(2):962-8. (PMID: 6130063)
Nature. 2001 Jul 26;412(6845):442-5. (PMID: 11473319)
J Clin Microbiol. 1987 Jan;25(1):110-4. (PMID: 3539984)
Infect Immun. 1992 Jun;60(6):2297-304. (PMID: 1350273)
Infect Genet Evol. 2003 Jul;3(2):111-7. (PMID: 12809805)
Infect Immun. 1995 Apr;63(4):1318-28. (PMID: 7890389)
J Pediatr Gastroenterol Nutr. 2001 Jul;33(1):32-40. (PMID: 11479405)
Infect Immun. 1989 Feb;57(2):649-52. (PMID: 2912902)
Annu Rev Microbiol. 2002;56:289-314. (PMID: 12142488)
Cell Microbiol. 2003 Aug;5(8):533-47. (PMID: 12864813)
J Bacteriol. 1999 Apr;181(7):2038-43. (PMID: 10094679)
J Bacteriol. 2008 Nov;190(22):7479-90. (PMID: 18790864)
J Med Microbiol. 2007 Jan;56(Pt 1):4-8. (PMID: 17172509)
J Clin Microbiol. 1995 Aug;33(8):2188-91. (PMID: 7559976)
Pediatr Res. 1993 Feb;33(2):205-8. (PMID: 8433897)
Mol Microbiol. 2004 Jan;51(1):283-96. (PMID: 14651628)
J Infect Dis. 1990 Jun;161(6):1249-51. (PMID: 2189007)
J Infect Dis. 1988 Jul;158(1):70-9. (PMID: 2899125)
Infect Immun. 1993 Feb;61(2):534-43. (PMID: 8423084)
Mol Microbiol. 2001 Sep;41(5):983-97. (PMID: 11555281)
Antimicrob Agents Chemother. 2007 Nov;51(11):3789-95. (PMID: 17698626)
Emerg Infect Dis. 1998 Apr-Jun;4(2):251-61. (PMID: 9621195)
FEMS Microbiol Lett. 2006 Jan;254(1):12-8. (PMID: 16451173)
Infect Immun. 2002 Dec;70(12):7153-5. (PMID: 12438400)
FEMS Immunol Med Microbiol. 2007 Nov;51(2):319-26. (PMID: 17714491)
J Gen Microbiol. 1971 Jul;67(1):91-7. (PMID: 4941950)
J Bacteriol. 1985 Dec;164(3):1238-47. (PMID: 2999074)
Microb Pathog. 1989 Apr;6(4):297-309. (PMID: 2569152)
Pediatrics. 2007 Jun;119(6):1120-30. (PMID: 17545379)
J Bacteriol. 1972 Jul;111(1):177-85. (PMID: 4591474)
Pediatrics. 2008 Feb;121(2):326-36. (PMID: 18245424)
Infect Immun. 2002 Aug;70(8):4302-11. (PMID: 12117939)
J Bacteriol. 1984 Oct;160(1):402-7. (PMID: 6090427)
J Infect Dis. 1998 Jan;177(1):88-96. (PMID: 9419174)

0 (Adhesins, Escherichia coli)
0 (Anti-Bacterial Agents)
0 (Escherichia coli Proteins)
0 (F pilin, E coli)
147680-16-8 (Fimbriae Proteins)
J41CSQ7QDS (Zinc)

Date Created: 20100224 Date Completed: 20100614 Latest Revision: 20211020

20221213

PMC2836999

10.1186/1471-2180-10-57

20175929